News Sentiment

BAX sentiment intelligence

Baxter International Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 47 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 22.62 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-0.1% over one week, +8.4% over four weeks, trend active, and below fair value.

Latest direct headline Negative

Is Baxter International (BAX) Cheap After Its Class I Recall And Segment Reshuffle?

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend active 8.4% over four weeks
Fair value -24.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 31
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
simplywall.st 4
Stock Titan 3
ad-hoc-news.de 2
MarketWatch 2
Moomoo 2
TradingView 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 6
Regulatory and legal 3
Analyst action 3
Guidance 2
Capital return 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
MarketWatch Direct company coverage

Baxter International Inc. stock outperforms competitors on strong trading day

Shares of Baxter International Inc. (BAX) rose by 5.42% to $23.35, outperforming the broader market on a day when the S&P 500 Index and Dow Jones Industrial Average both saw declines. This marks the second consecutive day of gains for the company's stock.

Tone
Positive 74/100
Event
Market update
Published
16 Jul 2026 17:14
Source
MarketWatch
Sahm Direct company coverage

Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)?

Baxter Healthcare recently initiated a voluntary FDA Class I recall of its Hillrom VOLARA System single-patient-use circuit kits due to nebulizer cup leakage issues, affecting over 10,000 units. This recall raises concerns about product quality and potential liability, adding to

Tone
Negative 29/100
Event
Regulatory and legal
Published
16 Jul 2026 11:37
Source
Sahm
The Globe and Mail Direct company coverage

Baxter International Updates Segment Reporting Structure and Metrics

Baxter International (BAX) has reorganized its reporting structure into two segments: Medical Products & Therapies and Healthcare Systems & Technologies, effective for the quarter ended June 30, 2026. This change aims to improve decision-making and performance assessment. The com

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 09:07
Source
The Globe and Mail
Stock Traders Daily Direct company coverage

How Baxter International Inc. (BAX) Affects Rotational Strategy Timing

This article analyzes Baxter International Inc. (BAX) using AI-generated signals and multi-timeframe analysis to guide rotational strategy timing. It notes weak near-term sentiment but strong mid-term prospects within a broader weak long-term bias. The analysis provides specific

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 21:58
Source
Stock Traders Daily
Moomoo Direct company coverage

Press Release: Biogen Appoints Michael J. Parini as Chief Legal Officer

Biogen has announced the appointment of Michael J. Parini as its new Chief Legal Officer, effective August 10, replacing Susan Alexander who is retiring. Parini brings extensive experience from his previous roles at Zimmer Biomet, Baxalta, and Baxter, and will be responsible for

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 12:37
Source
Moomoo
24/7 Wall St. Direct company coverage

AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap

This article analyzes a "golden cross" technical signal for both AbbVie (ABBV) and Baxter International (BAX), evaluating which stock is better suited for an income-focused retirement portfolio. It concludes that AbbVie is a clear winner due to its robust dividend, strong financi

Tone
Negative 19/100
Event
Capital return
Published
15 Jul 2026 11:46
Source
24/7 Wall St.
TradingView Direct company coverage

Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics

Baxter has reorganized its reporting structure from three segments to two: Medical Products & Therapies and Healthcare Systems & Technologies. This change involves recasting prior-period financials for comparability, including moving the former Pharmaceuticals segment and updatin

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 20:23
Source
TradingView
Stock Titan Direct company coverage

Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss

Baxter International Inc. has reorganized its reporting structure into two segments, Medical Products & Therapies (MPT) and Healthcare Systems & Technologies (HST), starting Q2 2026. The company provided recast financial data for 2024-2025 and recent quarters to align with this n

Tone
Negative 38/100
Event
Market update
Published
14 Jul 2026 20:16
Source
Stock Titan
MarketWatch Direct company coverage

Baxter International Inc. stock outperforms competitors despite losses on the day

Baxter International Inc. (BAX) experienced a 3.41% drop in its stock price, closing at $21.80 on Tuesday. Despite this loss, the stock still outperformed competitors on a day when the broader market saw gains, with the S&P 500 Index rising 0.38% and the Dow Jones Industrial Aver

Tone
Negative 38/100
Event
Market update
Published
14 Jul 2026 17:15
Source
MarketWatch
TradingView Direct company coverage

ETFs Investing in Baxter International Inc. Stocks

This article lists various ETFs that include Baxter International Inc. (BAX) stocks in their holdings. The detailed table provides information on each fund, such as market value, weight of BAX in the fund, issuer, management style, focus, expense ratio, assets under management (A

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 06:17
Source
TradingView
Ad Hoc News Direct company coverage

Baxter stock reflects a diversified medical technology business

The article highlights Baxter International Inc. as a global medical technology company offering a diversified portfolio across hospital products, renal care, and advanced infusion systems. It emphasizes Baxter's broad exposure to healthcare demand through essential clinical solu

Tone
Neutral 50/100
Event
Macro sensitivity
Published
10 Jul 2026 16:59
Source
Ad Hoc News
timothysykes.com Direct company coverage

Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Baxter International Inc. (BAX) on the NYSE, showing its current price and daily change. It notes that there is no analyst rating or earnings information available for BAX, and encourages users to get real-time quotes. The page

Tone
Negative 38/100
Event
Analyst action
Published
09 Jul 2026 22:37
Source
timothysykes.com
Law360 Direct company coverage

Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good

Baxter International has successfully defeated a proposed class action lawsuit arguing that the low returns of its employee retirement plan were evidence of mismanagement. An Illinois federal judge ruled in favor of Baxter, permanently settling the case. The lawsuit, Clinton v. B

Tone
Positive 71/100
Event
Regulatory and legal
Published
09 Jul 2026 21:07
Source
Law360
Business Wire Direct company coverage

Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX) will host a conference call on Thursday, July 30, 2026, at 7:30 a.m. Central Time, to discuss its second-quarter 2026 financial results. Investors and interested parties can pre-register for the call or access the webcast through the company's

Tone
Neutral 50/100
Event
Earnings
Published
09 Jul 2026 20:07
Source
Business Wire